AMRX (STOCKS)
Amneal Pharmaceuticals, Inc. Class A Common Stock
$14.700000
-0.060000 (-0.41%)
Prev close: $14.760000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Chintu Patel
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $4,694.32M
- Employees
- 8,100
- P/E (TTM)
- 1,039.44
- P/B (TTM)
- -42.21
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $2.93B |
| Benefits Costs and Expenses | $2.87B |
| Cost Of Revenue | $1.86B |
| Costs And Expenses | $2.87B |
| Gross Profit | $1.08B |
| Nonoperating Income/Loss | -$289.20M |
| Operating Expenses | $721.14M |
| Selling, General, and Administrative Expenses | $509.06M |
| Research and Development | $205.62M |
| Other Operating Expenses | $6.46M |
| Operating Income/Loss | $357.86M |
| Income/Loss From Continuing Operations After Tax | $57.62M |
| Income/Loss From Continuing Operations Before Tax | $68.66M |
| Income Tax Expense/Benefit | $11.04M |
| Net Income/Loss | $57.62M |
| Net Income/Loss Attributable To Noncontrolling Interest | $51.72M |
| Net Income/Loss Attributable To Parent | $5.90M |
| Net Income/Loss Available To Common Stockholders, Basic | $5.90M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $0.02 |
| Diluted Earnings Per Share | $0.01 |
| Basic Average Shares | 939,254,000 |
| Diluted Average Shares | 971,371,000 |
| Assets | $3.60B |
| Current Assets | $1.84B |
| Inventory | $614.50M |
| Other Current Assets | $1.22B |
| Noncurrent Assets | $1.76B |
| Fixed Assets | $434.99M |
| Intangible Assets | $587.94M |
| Other Non-current Assets | $738.47M |
| Liabilities | $3.64B |
| Current Liabilities | $862.11M |
| Accounts Payable | $266.36M |
| Wages | $63.90M |
| Other Current Liabilities | $531.85M |
| Noncurrent Liabilities | $2.78B |
| Long-term Debt | $2.57B |
| Other Non-current Liabilities | $206.24M |
| Equity | -$109.96M |
| Equity Attributable To Noncontrolling Interest | -$497.00K |
| Equity Attributable To Parent | -$109.46M |
| Temporary Equity | $67.78M |
| Liabilities And Equity | $3.60B |
| Net Cash Flow From Operating Activities | $327.76M |
| Net Cash Flow From Operating Activities, Continuing | $327.76M |
| Net Cash Flow From Investing Activities | -$82.87M |
| Net Cash Flow From Investing Activities, Continuing | -$82.87M |
| Net Cash Flow From Financing Activities | -$82.61M |
| Net Cash Flow From Financing Activities, Continuing | -$82.61M |
| Exchange Gains/Losses | -$2.21M |
| Net Cash Flow | $160.06M |
| Net Cash Flow, Continuing | $162.27M |
| Comprehensive Income/Loss | -$26.20M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$26.20M |
| Other Comprehensive Income/Loss | -$83.82M |
| Other Comprehensive Income/Loss Attributable To Parent | -$32.10M |